Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Harvard Bioscience, Inc. (HBIO : NSDQ)
 
 • Company Description   
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.

Number of Employees: 494

 
 • Price / Volume Information   
Yesterday's Closing Price: $3.19 Daily Weekly Monthly
20 Day Moving Average: 138,559 shares
Shares Outstanding: 41.64 (millions)
Market Capitalization: $132.82 (millions)
Beta: 1.71
52 Week High: $8.48
52 Week Low: $3.10
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -12.60% -19.03%
12 Week -14.93% -20.81%
Year To Date -54.75% -49.54%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
84 OCTOBER HILL RD
-
HOLLISTON,MA 01746
USA
ph: 508-893-8999
fax: 508-429-5732
info@harvardbioscience.com http://www.harvardbioscience.com
 
 • General Corporate Information   
Officers
James Green - Chief Executive Officer and Director
Michael A. Rossi - Chief Financial Officer
Katherine A. Eade - Director
Alan Edrick - Director
Thomas W. Loewald - Director

Peer Information
Harvard Bioscience, Inc. (DNEX)
Harvard Bioscience, Inc. (T.PUR)
Harvard Bioscience, Inc. (CALP)
Harvard Bioscience, Inc. (CCSI.)
Harvard Bioscience, Inc. (NEWP.)
Harvard Bioscience, Inc. (MTD)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: INSTRU-SCIENTFC
Sector: Computer and Technology
CUSIP: 416906105
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/22
Next Expected EPS Date: 11/02/22
Share - Related Items
Shares Outstanding: 41.64
Most Recent Split Date: (:1)
Beta: 1.71
Market Capitalization: $132.82 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.03 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.05 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 11/02/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 63.80
Trailing 12 Months: 22.79
PEG Ratio: -
Price Ratios
Price/Book: 1.71
Price/Cash Flow: 8.31
Price / Sales: 1.10
EPS Growth
vs. Year Ago Period: -50.00%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: 0.04%
vs. Previous Quarter: 1.49%
ROE
06/30/22 - 7.74
03/31/22 - 9.06
12/31/21 - 9.78
ROA
06/30/22 - 3.86
03/31/22 - 4.55
12/31/21 - 4.97
Current Ratio
06/30/22 - 2.42
03/31/22 - 2.18
12/31/21 - 2.43
Quick Ratio
06/30/22 - 1.16
03/31/22 - 1.13
12/31/21 - 1.34
Operating Margin
06/30/22 - 5.03
03/31/22 - 5.92
12/31/21 - 6.50
Net Margin
06/30/22 - -3.03
03/31/22 - -5.38
12/31/21 - -0.24
Pre-Tax Margin
06/30/22 - -2.01
03/31/22 - -5.36
12/31/21 - -0.12
Book Value
06/30/22 - 1.86
03/31/22 - 1.85
12/31/21 - 2.04
Inventory Turnover
06/30/22 - 1.86
03/31/22 - 1.96
12/31/21 - 2.03
Debt-to-Equity
06/30/22 - 0.59
03/31/22 - 0.61
12/31/21 - 0.54
Debt-to-Capital
06/30/22 - 37.13
03/31/22 - 37.71
12/31/21 - 35.09
 

Powered by Zacks Investment Research ©